The phrase "a range of surrogate" is correct and usable in written English.
It can be used when referring to various types or categories of surrogate options, such as in research, studies, or discussions about alternatives.
Example: "In our study, we examined a range of surrogate measures to evaluate the effectiveness of the treatment."
Alternatives: "a variety of substitutes" or "a selection of alternatives."
(Harrison, however, did accept delegations at his Indianapolis home.) The task of generating support fell to a range of surrogates, of which the Republicans could afford far more because of aggressive fundraising.
Though as an incumbent he kept with the tradition of "front porch" campaigning, a range of surrogates traveled the country on his behalf, trumpeting his accomplishments through speeches and the distribution of massive quantities of campaign literature.
This pre-defined sub-study of RECORD has the strength of being the first randomized clinical trial to compare add-on rosiglitazone combination therapy with both sulphonylureas and metformin against the standard combination of metformin + sulphonylurea, across a wide range of surrogate outcomes.
Interestingly, in the present and to date most comprehensive study of KRAS alterations in primary and metastatic lesions from endometrial carcinoma patients, we find that high KRAS mRNA expression and KRAS amplification, in contrast to KRAS mutation, are associated with a large range of surrogate markers for unfavourable outcome and poor disease-specific survival.
In the Inter99 study the type 2 diabetes risk alleles in the region between the CDC123 and the CAMK1D and in the TSPAN8 locus associated with a range of OGTT-based surrogate measures of serum insulin release [7].
The purpose of this prospective study was to compare the prognostic values of the FRS with a range of commonly used surrogate markers of atherosclerosis, used alone and in combination with the FRS, in Chinese T2DM patients identified as low-intermediate risk.
We report herein the results of a placebo-controlled trial that sought to define the effects of TCZ on a range of vascular risk surrogates in patients with RA.
Bioaccessibility studies using a wide range of surrogates for human fluids have provided exposure information for use in assessing the hazard characteristics or risks of chemicals.
A range of easy-to-calculate surrogate variables was developed and tested as possible candidates to improve the explanatory power of the IMD2000 access score.
Over recent years there has been great interest in the potential diagnostic value of a range of haematological, and immunological surrogate markers of infection [ 1, 2].
46 47 48 49 In this study we sought to address a different question that is, in the absence of final patient relevant outcomes, what is the potential effect of relying on the treatment effects based on surrogate outcomes across a range of medical conditions and interventions and surrogate outcome types?
